Members |
targetComponentId |
Cellulomonas fermentans |
Actinotalea fermentans (organism) |
Cellulose sodium phosphate 300g/bottle powder for oral suspension |
Cellulose only product in oral dose form |
Cemented total hip replacement: [primary] or [Charnley] |
Cemented arthroplasty of hip joint (procedure) |
Central cervical cord injury, without bony injury, C1-4 |
Central cord syndrome of cervical spinal cord at C1-4 level due to injury without spinal bony injury (disorder) |
Central cervical cord injury, without bony injury, C5-7 |
Central cord syndrome of cervical spinal cord at C5-7 level without bony injury (disorder) |
Central diabetes insipidus |
Vasopressin deficiency |
Central motor neuron |
Upper motor neuron |
Central nervous system (CNS) disorders NOS |
Disorder of the central nervous system (disorder) |
Central respiratory stimulant |
Respiratory stimulant (substance) |
Central sleep apnea caused by substance |
Central sleep apnea syndrome |
Central stimulant |
Central stimulant (substance) |
Central venous catheter associated bloodstream infection |
CLABSI - central line associated bloodstream infection |
Central venous catheter related bloodstream infection |
CLABSI - central line associated bloodstream infection |
Central venous catheter: [attention] or [removal Hickman] |
Removal of central venous line |
Centrally acting antihypertensive drug |
Centrally acting hypotensive agent (substance) |
Centrally acting hypotensive agent |
Centrally acting hypotensive agent (substance) |
Centrally acting muscle relaxant |
Centrally acting muscle relaxant (substance) |
Centrencephalic epilepsy |
A type of epilepsy with only generalised onset epileptic seizures. |
Centruroides sculpturatus |
Centruroides exilicauda |
Cephalad pubic bone dysfunction |
Superior pubic shear (finding) |
Cephalexin 125mg/5mL syrup |
Cefalexin 25 mg/mL oral solution |
Cephalexin 250mg/5mL syrup |
Cefalexin anhydrous (as cefalexin) 50 mg/mL oral solution |
Cephalexin monohydrate 250mg capsule |
Product containing precisely cefalexin 250 milligram/1 each conventional release oral capsule (clinical drug) |
Cephalexin monohydrate 500mg capsule |
Cefalexin 500 mg oral capsule |
Cephalic presentation |
Cephalic fetal presentation |
Cephalic version |
External cephalic version |
Cephalogram |
Plain X-ray cephalometry (procedure) |
Cephalometry X-ray |
Plain X-ray cephalometry (procedure) |
Cephalophus doria |
Cephalophus zebra (organism) |
Cephalotrichium |
Genus Strobilidium (organism) |
Cephapirin sodium 1g powder for injection solution vial |
Product containing precisely cefapirin (as cefapirin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Cercospora apii |
Mycocentrospora acerina |
Cereals food mix radioallergosorbent test |
Food mix specific IgE antibody measurement |
Cerebellar ataxia NOS |
Cerebellar ataxia |
Cerebellar ataxia NOS |
Cerebellar ataxia |
Cerebellar contusion with open intracranial wound and unspecified state of consciousness |
Cerebellar contusion with open intracranial wound |
Cerebellar contusion without open intracranial wound |
Cerebellar contusion |
Cerebellar contusion without open intracranial wound AND with concussion |
Cerebellar contusion |
Cerebellar contusion without open intracranial wound AND with loss of consciousness |
Cerebellar contusion |
Cerebellar contusion without open intracranial wound and with unspecified state of consciousness |
Cerebellar contusion |
Cerebellar laceration with open intracranial wound and unspecified state of consciousness |
Cerebellar laceration with open intracranial wound |
Cerebellar laceration without open intracranial wound |
Cerebellar laceration |
Cerebellar laceration without open intracranial wound AND with loss of consciousness |
Cerebellar laceration |
Cerebellar laceration without open intracranial wound and with unspecified state of consciousness |
Cerebellar laceration |
Cerebral artery occlusion NOS |
Cerebral artery occlusion |
Cerebral artery occlusion NOS |
Cerebral artery occlusion |
Cerebral gigantism jaw cysts syndrome |
Gorlin syndrome |
Cerebral haemorrhage NOS |
Cerebral hemorrhage |
Cerebral hemorrhage NOS |
Cerebral hemorrhage |
Cerebroretinal vasculopathy |
A rare genetic cerebral small vessel disease characterized by progressive loss of visual acuity due to retinal vasculopathy, in combination with more variable neurological signs and symptoms including stroke, cognitive decline, migraine-like headaches, and seizures, among others, typically beginning in middle age. Psychiatric features such as depression and anxiety may also occur. Systemic vascular involvement with Raynaud phenomenon, micronodular liver cirrhosis, and glomerular kidney dysfunction is present in a subset of patients. |
Cerebrospinal fluid appearance - NOS |
Cerebrospinal fluid appearance |
Cerebrospinal fluid cell content NOS |
Cell count, cerebrospinal fluid |
Cerebrospinal fluid chemistry - general NOS |
Determination of general chemical content of CSF |
Cerebrospinal fluid examination - general NOS |
Determination of general chemical content of CSF |
Cerebrospinal fluid examination NOS |
Cerebrospinal fluid examination |
Cerebrospinal fluid pressure NOS |
Cerebrospinal fluid pressure finding |
Cerebrospinal fluid: chloride level NOS |
CSF chloride measurement |
Cerebrospinal fluid: electrophoresis NOS |
Cerebrospinal fluid protein electrophoresis (procedure) |
Cerebrospinal fluid: globulin level NOS |
CSF globulin measurement |
Cerebrospinal fluid: microorganisms NOS |
Identification of microorganisms in CSF |
Cerebrospinal fluid: protein level NOS |
Measurement of protein in cerebrospinal fluid specimen (procedure) |
Cerebrovascular accident annual review |
Cerebrovascular accident annual review |
Cerebrovascular disease NOS |
Cerebrovascular disease |
Cerebrovascular disease NOS |
Cerebrovascular disease |
Certain procedure complications NOS |
Complication of procedure |
Certoparin sodium |
Product containing certoparin (medicinal product) |
Ceruloplasmin |
Ferroxidase |
Cervical approach |
Transcervical approach - uterine |
Cervical discography |
Discography with injection of contrast into intervertebral disc of cervical spine |
Cervical flap |
Flap (substance) |
Cervical incompetence with antenatal problem |
Cervical incompetence |
Cervical incompetence with postnatal complication |
Cervical incompetence |
Cervical lymphangiogram |
Fluoroscopic lymphangiography of neck with contrast (procedure) |
Cervical region flap |
Flap (substance) |
Cervical smear - inflammation NOS |
Cervical smear - inflammatory change |
Cervical smear - inflammation NOS |
Cervical smear - inflammatory change |
Cervical smear action NOS |
Cervical smear - action needed |
Cervical smear action NOS |
Cervical smear - action needed |
Cervical smear biopsy taken |
Sampling of cervix for Papanicolaou smear done (situation) |
Cervical smear biopsy taken |
Sampling of cervix for Papanicolaou smear done (situation) |
Cervical smear refused |
Screening for malignant neoplasm of cervix declined (situation) |
Cervical smear refused |
Screening for malignant neoplasm of cervix declined (situation) |
Cervical smear refused |
Screening for malignant neoplasm of cervix declined (situation) |
Cervical spine X-ray |
Plain X-ray of cervical spine |
Cervical spondylosis with myelopathy |
Myelopathy due to cervical spondylosis (disorder) |
Cervical spondylosis with myelopathy |
Myelopathy due to cervical spondylosis (disorder) |
Cervical spondylosis with radiculopathy |
Radiculopathy due to cervical spondylosis (disorder) |
Cervical syndrome, NEC |
Cervical syndrome |
Cervicohumeral fasciocutaneous flap |
Fasciocutaneous flap |
Cervicothoracic junction X-ray |
Plain X-ray of cervicothoracic junction of vertebral column |
Cervus elaphus bactrianus |
Cervus elaphus |
Cervus elaphus nannodes |
Cervus elaphus |
Cesarean delivery - delivered |
Deliveries by caesarean |
Cesarean delivery NOS |
Deliveries by caesarean |
Cesarean delivery unspecified |
Deliveries by caesarean |
Cesarean delivery without indication |
Cesarean section |
Cesarean wound disruption - delivered with postnatal complication |
Cesarean wound disruption (disorder) |
Cesarean wound disruption with postnatal complication |
Cesarean wound disruption (disorder) |
Cetirizine hydrochloride + pseudoephedrine 5mg/120mg m/r tablet |
Product containing only cetirizine and pseudoephedrine in oral dose form (medicinal product form) |
Cetirizine hydrochloride + pseudoephedrine 5mg/120mg prolonged-release oral tablet |
Product containing only cetirizine and pseudoephedrine in oral dose form (medicinal product form) |
Cetirizine hydrochloride 5mg/5 mL syrup |
Cetirizine hydrochloride 1 mg/mL oral solution |